Package 68788-4010-3

{"route": ["ORAL"], "spl_id": "069e6828-e599-4614-9645-9cf1382ac93e", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["069e6828-e599-4614-9645-9cf1382ac93e"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-4010-1)", "package_ndc": "68788-4010-1", "marketing_start_date": "20250904"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-4010-3)", "package_ndc": "68788-4010-3", "marketing_start_date": "20250904"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-4010-6)", "package_ndc": "68788-4010-6", "marketing_start_date": "20250904"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-4010-9)", "package_ndc": "68788-4010-9", "marketing_start_date": "20250904"}], "brand_name": "Bupropion hydrochloride", "product_id": "68788-4010_069e6828-e599-4614-9645-9cf1382ac93e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-4010", "generic_name": "Bupropion hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA215568", "marketing_category": "ANDA", "marketing_start_date": "20250904", "listing_expiration_date": "20261231"}